Current definitions and biomarkers used to identify partial remission (i.e., residual secretion [33,34] or IDAA1C score [24]) either require invasive blood sampling or present several limitations to describe the evolution of glycemic homeostasis (e.g., hypoglycemia, glycemic variability, insulin sensitivity) [20]. The gene discussed is INS; the disease is Hypoglycemia.